Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Hereditary Angioedema market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Hereditary Angioedema market. Detailed analysis of key players, along with key growth strategies adopted by Hereditary Angioedema industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Merck & Co., Inc.
Sanofi N.V.
ioCryst Pharmaceuticals
CSL
Pharming Group.
iBio
Shire
Ionis Pharmaceuticals
Teva Pharmaceutical Industries
Cipla, Inc
By Type:
Type I HAE
Type II HAE
Type III HAE
By End-User:
Hospitals
clinics
Research centers
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Hereditary Angioedema Market
-
1.3 Market Segment by Type
1.3.1 Japan Hereditary Angioedema Market Size and Growth Rate of Type I HAE from 2014 to 2026
1.3.2 Japan Hereditary Angioedema Market Size and Growth Rate of Type II HAE from 2014 to 2026
1.3.3 Japan Hereditary Angioedema Market Size and Growth Rate of Type III HAE from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Hereditary Angioedema Market Size and Growth Rate of Hospitals from 2014 to 2026
1.4.2 Japan Hereditary Angioedema Market Size and Growth Rate of clinics from 2014 to 2026
1.4.3 Japan Hereditary Angioedema Market Size and Growth Rate of Research centers from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Hereditary Angioedema Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Hereditary Angioedema by Major Types
3.4.1 Market Size and Growth Rate of Type I HAE
3.4.2 Market Size and Growth Rate of Type II HAE
3.4.3 Market Size and Growth Rate of Type III HAE
4 Segmentation of Hereditary Angioedema Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Hereditary Angioedema by Major End-Users
4.4.1 Market Size and Growth Rate of Hereditary Angioedema in Hospitals
4.4.2 Market Size and Growth Rate of Hereditary Angioedema in clinics
4.4.3 Market Size and Growth Rate of Hereditary Angioedema in Research centers
5 Market Analysis by Regions
-
5.1 Japan Hereditary Angioedema Production Analysis by Regions
-
5.2 Japan Hereditary Angioedema Consumption Analysis by Regions
6 Hokkaido Hereditary Angioedema Landscape Analysis
-
6.1 Hokkaido Hereditary Angioedema Landscape Analysis by Major Types
-
6.2 Hokkaido Hereditary Angioedema Landscape Analysis by Major End-Users
7 Tohoku Hereditary Angioedema Landscape Analysis
-
7.1 Tohoku Hereditary Angioedema Landscape Analysis by Major Types
-
7.2 Tohoku Hereditary Angioedema Landscape Analysis by Major End-Users
8 Kanto Hereditary Angioedema Landscape Analysis
-
8.1 Kanto Hereditary Angioedema Landscape Analysis by Major Types
-
8.2 Kanto Hereditary Angioedema Landscape Analysis by Major End-Users
9 Chubu Hereditary Angioedema Landscape Analysis
-
9.1 Chubu Hereditary Angioedema Landscape Analysis by Major Types
-
9.2 Chubu Hereditary Angioedema Landscape Analysis by Major End-Users
10 Kinki Hereditary Angioedema Landscape Analysis
-
10.1 Kinki Hereditary Angioedema Landscape Analysis by Major Types
-
10.2 Kinki Hereditary Angioedema Landscape Analysis by Major End-Users
11 Chugoku Hereditary Angioedema Landscape Analysis
-
11.1 Chugoku Hereditary Angioedema Landscape Analysis by Major Types
-
11.2 Chugoku Hereditary Angioedema Landscape Analysis by Major End-Users
12 Shikoku Hereditary Angioedema Landscape Analysis
-
12.1 Shikoku Hereditary Angioedema Landscape Analysis by Major Types
-
12.2 Shikoku Hereditary Angioedema Landscape Analysis by Major End-Users
13 Kyushu Hereditary Angioedema Landscape Analysis
-
13.1 Kyushu Hereditary Angioedema Landscape Analysis by Major Types
-
13.2 Kyushu Hereditary Angioedema Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Merck & Co., Inc.
14.1.1 Merck & Co., Inc. Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Sanofi N.V.
14.2.1 Sanofi N.V. Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 ioCryst Pharmaceuticals
14.3.1 ioCryst Pharmaceuticals Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 CSL
14.4.1 CSL Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Pharming Group.
14.5.1 Pharming Group. Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 iBio
14.6.1 iBio Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Shire
14.7.1 Shire Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Ionis Pharmaceuticals
14.8.1 Ionis Pharmaceuticals Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Teva Pharmaceutical Industries
14.9.1 Teva Pharmaceutical Industries Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Cipla, Inc
14.10.1 Cipla, Inc Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
The List of Tables and Figures (Totals 107 Figures and 148 Tables)
Figure Japan Hereditary Angioedema Market Size and Growth Rate of Type I HAE from 2014 to 2026
Figure Japan Hereditary Angioedema Market Size and Growth Rate of Type II HAE from 2014 to 2026
Figure Japan Hereditary Angioedema Market Size and Growth Rate of Type III HAE from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Hereditary Angioedema Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Japan Hereditary Angioedema Market Size and Growth Rate of clinics from 2014 to 2026
Figure Japan Hereditary Angioedema Market Size and Growth Rate of Research centers from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Hereditary Angioedema Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Hereditary Angioedema Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Hereditary Angioedema
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Hereditary Angioedema by Different Types from 2014 to 2026
-
Table Consumption Share of Hereditary Angioedema by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Type I HAE
Figure Market Size and Growth Rate of Type II HAE
Figure Market Size and Growth Rate of Type III HAE
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Hereditary Angioedema by Different End-Users from 2014 to 2026
-
Table Consumption Share of Hereditary Angioedema by Different End-Users from 2014 to 2026
Figure Japan Hereditary Angioedema Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Japan Hereditary Angioedema Market Size and Growth Rate of clinics from 2014 to 2026
Figure Japan Hereditary Angioedema Market Size and Growth Rate of Research centers from 2014 to 2026
-
Table Japan Hereditary Angioedema Production by Regions
-
Table Japan Hereditary Angioedema Production Share by Regions
-
Figure Japan Hereditary Angioedema Production Share by Regions in 2014
-
Figure Japan Hereditary Angioedema Production Share by Regions in 2018
-
Figure Japan Hereditary Angioedema Production Share by Regions in 2026
-
Table Japan Hereditary Angioedema Consumption by Regions
-
Table Japan Hereditary Angioedema Consumption Share by Regions
-
Figure Japan Hereditary Angioedema Consumption Share by Regions in 2014
-
Figure Japan Hereditary Angioedema Consumption Share by Regions in 2018
-
Figure Japan Hereditary Angioedema Consumption Share by Regions in 2026
-
Table Hokkaido Hereditary Angioedema Consumption by Types from 2014 to 2026
-
Table Hokkaido Hereditary Angioedema Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Hereditary Angioedema Consumption Share by Types in 2014
-
Figure Hokkaido Hereditary Angioedema Consumption Share by Types in 2018
-
Figure Hokkaido Hereditary Angioedema Consumption Share by Types in 2026
-
Table Hokkaido Hereditary Angioedema Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Hereditary Angioedema Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Hereditary Angioedema Consumption Share by End-Users in 2014
-
Figure Hokkaido Hereditary Angioedema Consumption Share by End-Users in 2018
-
Figure Hokkaido Hereditary Angioedema Consumption Share by End-Users in 2026
-
Table Tohoku Hereditary Angioedema Consumption by Types from 2014 to 2026
-
Table Tohoku Hereditary Angioedema Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Hereditary Angioedema Consumption Share by Types in 2014
-
Figure Tohoku Hereditary Angioedema Consumption Share by Types in 2018
-
Figure Tohoku Hereditary Angioedema Consumption Share by Types in 2026
-
Table Tohoku Hereditary Angioedema Consumption by End-Users from 2014 to 2026
-
Table Tohoku Hereditary Angioedema Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Hereditary Angioedema Consumption Share by End-Users in 2014
-
Figure Tohoku Hereditary Angioedema Consumption Share by End-Users in 2018
-
Figure Tohoku Hereditary Angioedema Consumption Share by End-Users in 2026
-
Table Kanto Hereditary Angioedema Consumption by Types from 2014 to 2026
-
Table Kanto Hereditary Angioedema Consumption Share by Types from 2014 to 2026
-
Figure Kanto Hereditary Angioedema Consumption Share by Types in 2014
-
Figure Kanto Hereditary Angioedema Consumption Share by Types in 2018
-
Figure Kanto Hereditary Angioedema Consumption Share by Types in 2026
-
Table Kanto Hereditary Angioedema Consumption by End-Users from 2014 to 2026
-
Table Kanto Hereditary Angioedema Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Hereditary Angioedema Consumption Share by End-Users in 2014
-
Figure Kanto Hereditary Angioedema Consumption Share by End-Users in 2018
-
Figure Kanto Hereditary Angioedema Consumption Share by End-Users in 2026
-
Table Chubu Hereditary Angioedema Consumption by Types from 2014 to 2026
-
Table Chubu Hereditary Angioedema Consumption Share by Types from 2014 to 2026
-
Figure Chubu Hereditary Angioedema Consumption Share by Types in 2014
-
Figure Chubu Hereditary Angioedema Consumption Share by Types in 2018
-
Figure Chubu Hereditary Angioedema Consumption Share by Types in 2026
-
Table Chubu Hereditary Angioedema Consumption by End-Users from 2014 to 2026
-
Table Chubu Hereditary Angioedema Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Hereditary Angioedema Consumption Share by End-Users in 2014
-
Figure Chubu Hereditary Angioedema Consumption Share by End-Users in 2018
-
Figure Chubu Hereditary Angioedema Consumption Share by End-Users in 2026
-
Table Kinki Hereditary Angioedema Consumption by Types from 2014 to 2026
-
Table Kinki Hereditary Angioedema Consumption Share by Types from 2014 to 2026
-
Figure Kinki Hereditary Angioedema Consumption Share by Types in 2014
-
Figure Kinki Hereditary Angioedema Consumption Share by Types in 2018
-
Figure Kinki Hereditary Angioedema Consumption Share by Types in 2026
-
Table Kinki Hereditary Angioedema Consumption by End-Users from 2014 to 2026
-
Table Kinki Hereditary Angioedema Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Hereditary Angioedema Consumption Share by End-Users in 2014
-
Figure Kinki Hereditary Angioedema Consumption Share by End-Users in 2018
-
Figure Kinki Hereditary Angioedema Consumption Share by End-Users in 2026
-
Table Chugoku Hereditary Angioedema Consumption by Types from 2014 to 2026
-
Table Chugoku Hereditary Angioedema Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Hereditary Angioedema Consumption Share by Types in 2014
-
Figure Chugoku Hereditary Angioedema Consumption Share by Types in 2018
-
Figure Chugoku Hereditary Angioedema Consumption Share by Types in 2026
-
Table Chugoku Hereditary Angioedema Consumption by End-Users from 2014 to 2026
-
Table Chugoku Hereditary Angioedema Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Hereditary Angioedema Consumption Share by End-Users in 2014
-
Figure Chugoku Hereditary Angioedema Consumption Share by End-Users in 2018
-
Figure Chugoku Hereditary Angioedema Consumption Share by End-Users in 2026
-
Table Shikoku Hereditary Angioedema Consumption by Types from 2014 to 2026
-
Table Shikoku Hereditary Angioedema Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Hereditary Angioedema Consumption Share by Types in 2014
-
Figure Shikoku Hereditary Angioedema Consumption Share by Types in 2018
-
Figure Shikoku Hereditary Angioedema Consumption Share by Types in 2026
-
Table Shikoku Hereditary Angioedema Consumption by End-Users from 2014 to 2026
-
Table Shikoku Hereditary Angioedema Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Hereditary Angioedema Consumption Share by End-Users in 2014
-
Figure Shikoku Hereditary Angioedema Consumption Share by End-Users in 2018
-
Figure Shikoku Hereditary Angioedema Consumption Share by End-Users in 2026
-
Table Kyushu Hereditary Angioedema Consumption by Types from 2014 to 2026
-
Table Kyushu Hereditary Angioedema Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Hereditary Angioedema Consumption Share by Types in 2014
-
Figure Kyushu Hereditary Angioedema Consumption Share by Types in 2018
-
Figure Kyushu Hereditary Angioedema Consumption Share by Types in 2026
-
Table Kyushu Hereditary Angioedema Consumption by End-Users from 2014 to 2026
-
Table Kyushu Hereditary Angioedema Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Hereditary Angioedema Consumption Share by End-Users in 2014
-
Figure Kyushu Hereditary Angioedema Consumption Share by End-Users in 2018
-
Figure Kyushu Hereditary Angioedema Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Merck & Co., Inc.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co., Inc.
Figure Sales and Growth Rate Analysis of Merck & Co., Inc.
Figure Revenue and Market Share Analysis of Merck & Co., Inc.
Table Product and Service Introduction of Merck & Co., Inc.
Table Company Profile and Development Status of Sanofi N.V.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi N.V.
Figure Sales and Growth Rate Analysis of Sanofi N.V.
Figure Revenue and Market Share Analysis of Sanofi N.V.
Table Product and Service Introduction of Sanofi N.V.
Table Company Profile and Development Status of ioCryst Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ioCryst Pharmaceuticals
Figure Sales and Growth Rate Analysis of ioCryst Pharmaceuticals
Figure Revenue and Market Share Analysis of ioCryst Pharmaceuticals
Table Product and Service Introduction of ioCryst Pharmaceuticals
Table Company Profile and Development Status of CSL
Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL
Figure Sales and Growth Rate Analysis of CSL
Figure Revenue and Market Share Analysis of CSL
Table Product and Service Introduction of CSL
Table Company Profile and Development Status of Pharming Group.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharming Group.
Figure Sales and Growth Rate Analysis of Pharming Group.
Figure Revenue and Market Share Analysis of Pharming Group.
Table Product and Service Introduction of Pharming Group.
Table Company Profile and Development Status of iBio
Table Sales, Revenue, Sales Price and Gross Margin Analysis of iBio
Figure Sales and Growth Rate Analysis of iBio
Figure Revenue and Market Share Analysis of iBio
Table Product and Service Introduction of iBio
Table Company Profile and Development Status of Shire
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire
Figure Sales and Growth Rate Analysis of Shire
Figure Revenue and Market Share Analysis of Shire
Table Product and Service Introduction of Shire
Table Company Profile and Development Status of Ionis Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ionis Pharmaceuticals
Figure Sales and Growth Rate Analysis of Ionis Pharmaceuticals
Figure Revenue and Market Share Analysis of Ionis Pharmaceuticals
Table Product and Service Introduction of Ionis Pharmaceuticals
Table Company Profile and Development Status of Teva Pharmaceutical Industries
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries
Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries
Table Product and Service Introduction of Teva Pharmaceutical Industries
Table Company Profile and Development Status of Cipla, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla, Inc
Figure Sales and Growth Rate Analysis of Cipla, Inc
Figure Revenue and Market Share Analysis of Cipla, Inc
Table Product and Service Introduction of Cipla, Inc
-
